Trials / Conditions / Lobular Carcinoma in Situ
Lobular Carcinoma in Situ
6 registered clinical trials studyying Lobular Carcinoma in Situ — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | CAN1012 in Pre-Malignant DCIS and LCIS NCT07408856 | Providence Health & Services | Phase 1 |
| Withdrawn | Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast L NCT03868475 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | N/A |
| Active Not Recruiting | Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion NCT06033092 | European Institute of Oncology | Phase 2 |
| Completed | Ruxolitinib for Premalignant Breast Disease NCT02928978 | Julie Nangia | Phase 2 |
| Terminated | Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer NCT02137252 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Molecular Breast Imaging in Women With Atypia and LCIS NCT00620087 | Mayo Clinic | N/A |